Search
for
Sort by
Research 181–210 of 410
- Prostatic irradiation-induced sexual dysfunction: A review and multidisciplinary guide to management in the radical radiotherapy era (Part III on Psychosexual Therapy and the Masculine Self-Esteem)
- Safety and quality of life of CDK4/6 inhibitors therapy for hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer: a multicenter cross-sectional survey in China
- Mucocutaneous findings in hematolymphoid neoplasms: An observational study
- When bugs and drugs conspire: driving acneiform skin toxicity
- Efficacy of penguin cap as scalp cooling system for prevention of alopecia in patients undergoing chemotherapy
- Hair loss during and after breast cancer therapy
- Nilotinib-induced generalized keratosis pilaris: Report of a rare case
- Chemotherapy and Cutaneous Drug Reactions
- Optimizing treatment management of trastuzumab deruxtecan in clinical practice of breast cancer
- Skin ultrasonography and magnetic resonance; new clinical applications and instrumentation
- Cutaneous adverse events to systemic antineoplastic therapies: a retrospective study in a public oncologic hospital
- The sternum reconstruction: Present and future perspectives
- Pediatric Dermatopathology
- Ensuring safety in cytotoxic drug preparation: A systematic review of guidelines addressing education for pharmacy professionals
- Whole brain radiotherapy with partial hair-sparing technique-a feasibility study
- Treatment of Chemotherapy Induced Alopecia
- ARTIFICIAL INTELLIGENCE DERMOSCOPY AND A-T ADVANCEMENT FLAP FOR BASAL CELL CARCINOMA OF THE SCALP
- Virilizing Leydig cell tumor of the ovary: from presentation to treatment - a case report
- Hirsutism as the initial presentation of malignant ovarian Leydig cell tumor: A case report
- Cutaneous Side Effects of Modern Targeted Therapy and Immunotherapy in Patients with Dermatological Malignancies
- Reply to comment on: The Gabrin sign
- Antibody Drug Conjugates
- Abstract P1-09-32: A novel candidate for chemotherapy induced alopecia (CIA) through local modulation of apoptosis and inflammation
- Efeitos da finasterida sobre culturas de células epiteliais prostáticas normais e tumorais em diferentes sistemas in vitro
- First National Chemotherapy Safety Standards Issued Jointly by ASCO & ONS
- Multicentric parallel phase II trial of the polo-like kinase 1 inhibitor BI 2536 in patients with advanced head and neck cancer, breast cancer, ovarian cancer, soft tissue sarcoma and melanoma. The first protocol of the European Organization for Research and Treatment of Cancer (EORTC) Network Of Core Institutes (NOCI)
- Management of Sexual Dysfunction in Postmenopausal Breast Cancer Patients Taking Adjuvant Aromatase Inhibitor Therapy
- Efficacy and Skin Toxicity Management with Cetuximab in Metastatic Colorectal Cancer: Outcomes from an Oncologic/Dermatologic Cooperation
- Scarring alopecia associated with the epidermal growth factor receptor inhibitor erlotinib
- Oral minoxidil for late alopecia in cancer survivors